355 related articles for article (PubMed ID: 11509027)
1. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
Zhou S; Heller LJ; Wallace KB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
[TBL] [Abstract][Full Text] [Related]
2. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
Zhou S; Starkov A; Froberg MK; Leino RL; Wallace KB
Cancer Res; 2001 Jan; 61(2):771-7. PubMed ID: 11212281
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin.
Solem LE; Heller LJ; Wallace KB
J Mol Cell Cardiol; 1996 May; 28(5):1023-32. PubMed ID: 8762040
[TBL] [Abstract][Full Text] [Related]
4. Altered ionic calcium and cell motion in ventricular myocytes after cutaneous thermal injury.
Koshy US; Burton KP; Le TH; Horton JW
J Surg Res; 1997 Mar; 68(2):133-8. PubMed ID: 9184671
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage.
Emanuelov AK; Shainberg A; Chepurko Y; Kaplan D; Sagie A; Porat E; Arad M; Hochhauser E
Biochem Pharmacol; 2010 Jan; 79(2):180-7. PubMed ID: 19686702
[TBL] [Abstract][Full Text] [Related]
6. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
[TBL] [Abstract][Full Text] [Related]
7. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential.
Xu M; Ashraf M
J Mol Cell Cardiol; 2002 Jan; 34(1):75-9. PubMed ID: 11812166
[TBL] [Abstract][Full Text] [Related]
8. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios.
Dorr RT; Bozak KA; Shipp NG; Hendrix M; Alberts DS; Ahmann F
Cancer Res; 1988 Sep; 48(18):5222-7. PubMed ID: 3409247
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
Bottone AE; Voest EE; de Beer EL
Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
[TBL] [Abstract][Full Text] [Related]
10. Effects of beauvericin on the metabolic state and ionic homeostasis of ventricular myocytes of the guinea pig.
Kouri K; Duchen MR; Lemmens-Gruber R
Chem Res Toxicol; 2005 Nov; 18(11):1661-8. PubMed ID: 16300374
[TBL] [Abstract][Full Text] [Related]
11. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.
Solem LE; Henry TR; Wallace KB
Toxicol Appl Pharmacol; 1994 Dec; 129(2):214-22. PubMed ID: 7527602
[TBL] [Abstract][Full Text] [Related]
12. Shear fluid-induced Ca2+ release and the role of mitochondria in rat cardiac myocytes.
Belmonte S; Morad M
Ann N Y Acad Sci; 2008 Mar; 1123():58-63. PubMed ID: 18375577
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
14. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
15. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
16. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
17. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
Berthiaume JM; Wallace KB
Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage.
Cardoso S; Santos RX; Carvalho C; Correia S; Pereira GC; Pereira SS; Oliveira PJ; Santos MS; Proença T; Moreira PI
Free Radic Biol Med; 2008 Nov; 45(10):1395-402. PubMed ID: 18775776
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
Consolini AE; Ragone MI; Conforti P; Volonté MG
Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
[TBL] [Abstract][Full Text] [Related]
20. Cobra venom cardiotoxin induces perturbations of cytosolic calcium homeostasis and hypercontracture in adult rat ventricular myocytes.
Wang HX; Lau SY; Huang SJ; Kwan CY; Wong TM
J Mol Cell Cardiol; 1997 Oct; 29(10):2759-70. PubMed ID: 9344770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
